Firm, intensely itchy bumps that you can't stop scratching — and that exist because of the scratching — define prurigo nodularis. It's one of the itchiest conditions in dermatology, and modern treatment can finally break the loop.
Prurigo nodularis ('picker's nodules') is a chronic condition in which repeated scratching drives the skin to form firm, dome-shaped, extremely itchy nodules — which provoke more scratching. Nodules cluster where hands reach easily: arms, legs, upper back and torso. Treatment combines aggressive itch control, protecting the skin from scratching, and treating any underlying cause of the original itch; newer biologic medicines have transformed severe cases.
Prurigo nodularis begins with itch — from eczema, dry skin, insect bites, kidney or liver disease, diabetes, thyroid problems, HIV, or sometimes no identifiable cause. Sustained scratching then rewires the local skin: nerve fibers proliferate and sensitize, the skin thickens defensively, and firm nodules form that itch far more intensely than the surrounding skin. At that point the nodules are self-sustaining — the original trigger may be long gone while the cycle continues.
The picture is distinctive: dozens to hundreds of firm, symmetric bumps, 0.5–3 cm, often darker than surrounding skin (especially in deeper skin tones), frequently topped with scratch marks, crusts or scars — and a telltale clear zone in the middle of the upper back, the one spot hands can't reach (the 'butterfly sign'). Itch is severe, often worst at night, and the impact on sleep and mental health is substantial and well documented. It is not contagious and not caused by poor hygiene.
Treatment attacks the cycle from several sides at once. Protect and treat the nodules: potent prescription topical steroids (often under occlusion), steroid injections into stubborn nodules, and covering favorite scratching targets so nails can't reach. Control the itch signal: high-dose non-drowsy antihistamines help some; capsaicin cream, menthol lotions and cool compresses give local relief; keeping skin generously moisturized raises the itch threshold. Trim nails, wear cotton gloves at night if you scratch in your sleep.
For moderate-to-severe disease, dermatology now has genuinely effective options: dupilumab, a biologic injection, is approved specifically for prurigo nodularis and substantially reduces itch and nodules, with other agents (like JAK inhibitors) in use or development. Phototherapy remains a solid option. Alongside skin treatment, a clinician should screen for underlying drivers — kidney, liver, thyroid, iron, diabetes, HIV — because treating those matters, and untreated depression or anxiety keeps the cycle spinning.
Telling someone with prurigo nodularis to stop scratching misunderstands the disease. The nodules contain a measurably increased density of sensitized itch-signaling nerve fibers; the itch is neurologically real and among the most intense in dermatology, and much scratching happens during sleep, beyond voluntary control. What actually works is lowering the itch signal medically (potent topicals, injections, biologics like dupilumab), physically blocking sleep-scratching (occlusion, night gloves), and treating the systemic and psychological amplifiers. People who finally reach effective treatment routinely describe it as life-changing — a reason to see a dermatologist rather than fight the cycle alone.
We use established public-health and dermatology references and link them directly so you can verify the guidance and read further.
Chronic scratching in response to itch — from eczema, dry skin, systemic disease or unknown causes — drives nerve proliferation and skin thickening that forms self-sustaining, intensely itchy nodules. The original trigger may be gone while the cycle continues.
Established nodules rarely vanish on their own because they itch too intensely to leave alone, including during sleep. With effective medical treatment, nodules flatten over months, though darker marks or scars can remain.
Mild cases: potent topical steroids, steroid injections, itch-control measures and treating underlying causes. Moderate-to-severe disease now has approved biologic therapy — dupilumab — plus phototherapy and other options via a dermatologist.
Sometimes. It's associated with kidney and liver disease, thyroid problems, diabetes, iron deficiency and HIV, so new widespread prurigo warrants basic blood screening. Often, though, it follows eczema or has no identifiable systemic cause.
No. It cannot be passed to anyone. The important contagious mimic is nodular scabies — if household members also itch, scabies should be excluded first.
Scan them — RashScan helps distinguish prurigo, scabies and eczema patterns and tells you when a dermatologist visit matters.
Scan itchy nodulesEducational guidance only — not a medical diagnosis.